Manganese neurotoxicity: effects of varying oxygen tension and EDTA on dopamine auto-oxidation

Neurotoxicology
|January 1, 1987
PubMed

Insights

Excess manganese (Mn) accelerates dopamine oxidation, contributing to parkinsonism. This study shows Mn significantly increases dopamine auto-oxidation rates, especially under oxygen, suggesting a role for reactive oxygen species in Mn-induced neurotoxicity.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Manganese (Mn) is essential but toxic in excess, causing parkinsonism.
  • Mn is a potent stimulator of dopamine (DA) auto-oxidation compared to other metals.

Purpose of the Study:

  • To investigate the effect of manganese on dopamine auto-oxidation rates.
  • To explore the influence of oxygen levels and chelating agents on this process.

Main Methods:

  • Incubation of manganese and dopamine at 37°C.
  • Measurement of optical density at 480 nm to quantify aminochrome formation.
  • Varying partial pressures of oxygen (pO2) and using EDTA as a chelating agent.

Main Results:

  • Mn significantly increased DA auto-oxidation rates, particularly under elevated oxygen.
  • Air plus Mn showed a 5-fold greater oxidation rate than air or Mn alone.
  • EDTA reduced Mn-stimulated DA auto-oxidation by 80%.

Conclusions:

  • Results support the role of activated oxygen metabolites in dopamine depletion during chronic Mn intoxication.
  • Understanding Mn's effect on dopamine oxidation is crucial for neurodegenerative disease research.

Related Concept Videos

Radical Oxidation of Allylic and Benzylic Alcohols01:21

Radical Oxidation of Allylic and Benzylic Alcohols

Activated manganese(IV) oxide can selectively oxidize allylic and benzylic alcohols via a radical intermediate mechanism. Primary allylic alcohols are oxidized to aldehydes, while secondary allylic alcohols yield ketones. The redox reaction of potassium permanganate with an Mn(II) salt such as manganese sulfate (under either alkaline or acidic conditions), followed by thorough drying, yields the oxidizing agent: activated MnO2. While MnO2 is insoluble in the solvents used for the reaction, the...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Masking and Demasking Agents01:19

Masking and Demasking Agents

EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...